Borate-crosslinked guar gels are widely used for hydraulic fracturing treatment of wells at temperatures of about 100-300°F due to their advantages such as low cost, ability to reheal upon shearing and operational simplicity. These fluids, however, may lose some or even all of the gel viscosity under sufficient high pressure, especially at elevated downhole temperatures. Although this process could be reversed when the pressure and/or temperature drops, it may potentially cause adverse operational issues such as proppant screenout where the proppant cannot be placed.
Recently we found during the lab research studies that the viscosity loss of the borate-crosslinked guar fluids under high pressure could be mitigated with a number of novel nanomaterials. This paper examines three specific nanomaterials. These enhancing nanomaterials were applied to the borate-crosslinked guar gels as a liquid additive, with dosages typically at about 0.02%-0.12% by weight. In one example, the addition of 1 gpt of nanomaterial-I (0.02% active nanomaterials) enhanced the borate-guar fluid viscosity by about six times at the pressure of 8000 psi. In another example, when 2 gpt of nanomaterial-II (0.04% active nanomaterials) was added, the fluid viscosity was enhanced by about nine times under a pressure of 8000 psi. As the result, the viscosity boosted by nanomaterial-II under high pressure was more than enough for the fluid to function normally to render fractures and transport and place proppant. Other nanomaterials including nanomaterial-III also significantly reversed the high pressure-induced viscosity loss for the borate-crosslinked guar fluids.
These nanomaterials may have rendered more attractive interactions among the guar polymer chains, thus stabilizing the crosslinking of the fluids when the borate-guar bonding was reduced under elevated pressure and temperature. The detailed results of the lab tests at high pressure, as well as fluid chemistry will be discussed in this paper.
Two Ziegler-Natta and one metallocene supported catalysts were prepared that were used to synthesize ethylene homopolymers with different molecular weights. The influence of varying residual catalyst types and molecular weights on the isothermal crystallization kinetics of these polymers was studied using DSC and Avrami model to gain better understanding. The MetCat HomoPE, unlike the Z-N HomoPEs, followed the Avrami model during the entire crystallization. The increase in molecular weights did not affect (i) the decreasing trend of 1/t 1/2 (bulk crystallization rate) and K (crystallization rate constant) with the increase in T c (crystallization temperature), and (ii) the increasing trend of K with the increase in %crystallinity. However, combined with the varying residual catalysts, it differently varied the rate of change of 1/t 1/2 and K; and decreased T c . K and 1/t 1/2 turned out to be asymptotically related up to 1/t 1/2 ≈0.73 min −1 . The residual catalyst type more predominantly affected the crystallization facileness than the molecular weight. Therefore, the Z-N 1 residual catalyst acted as heterogeneous nuclei. In Z-N HomoPE 1 and Z-N HomoPE 2, n ranged from 2.2 to 3.4, and 2.6 to 3.0, respectively as a function of T c . In MetCat HomoPE, it remained constant at 2. Therefore, the MetCat residual catalyst impinged the expected spherulitic crystal growth to a two dimensional one. All these findings were explained considering how the molecular level residual catalysts, with their characteristic surface chemistries and structures, influenced the prevailing heterogeneous nucleation process, and the aliased interaction of G (nuclei growth rate) and Ñ (nucleation rate).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.